These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3723317)

  • 1. Possible active tubular secretion of sulfamonomethoxine and its metabolites in pigs.
    Shimoda M; Aihara E; Koyanagi M; Kokue E; Hayama T
    J Pharmacobiodyn; 1986 Mar; 9(3):229-33. PubMed ID: 3723317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of renal active secretion in renal excretion of N4-acetylsulfamonomethoxine in conscious pigs.
    Shimoda M; Kokue E; Tanaka N; Hayama T
    J Pharmacobiodyn; 1986 Nov; 9(11):865-70. PubMed ID: 3559878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of deacetylation in the nonlinear pharmacokinetics of sulfamonomethoxine in pigs.
    Shimoda M; Kokue E; Shimizu T; Muraoka R; Hayama T
    J Pharmacobiodyn; 1988 Aug; 11(8):576-82. PubMed ID: 3236216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic analysis of plasma concentration and urinary excretion of sulphamonomethoxine and its metabolite in Goettingen minipigs.
    Tsuboi T; Kokue E; Shimoda M; Hayama T
    J Vet Pharmacol Ther; 1984 Sep; 7(3):219-23. PubMed ID: 6492249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deacetylation as a determinant of sulphonamide pharmacokinetics in pigs.
    Shimoda M; Okamoto K; Sikazwe G; Fujii C; Son DS
    Vet Q; 1997 Nov; 19(4):186-91. PubMed ID: 9413118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations, plasma protein binding and residues of sulfamonomethoxine in pigs, horses and cattle.
    Rauws AG; van Schothorst M; Frik JF
    Tijdschr Diergeneeskd; 1975 Oct; 100(20):1099-104. PubMed ID: 1198573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of oral sulfa drugs and gastric emptying in the pig.
    Kokue E; Shimoda M; Sakurada K; Wada J
    J Pharmacobiodyn; 1988 Aug; 11(8):549-54. PubMed ID: 3236212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal tubular secretion and effects of furosemide.
    Odlind B; Beermann B
    Clin Pharmacol Ther; 1980 Jun; 27(6):784-90. PubMed ID: 7379446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coupling between renal tubular secretion and effect of bumetanide.
    Odlind B; Beermann B; Lindström B
    Clin Pharmacol Ther; 1983 Dec; 34(6):805-9. PubMed ID: 6641097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of renal tubular transport of methotrexate by probenecid.
    Bourke RS; Chheda G; Bremer A; Watanabe O; Tower DB
    Cancer Res; 1975 Jan; 35(1):110-6. PubMed ID: 1109785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubular mechanisms determining the urinary excretion of tritiated prostaglandin E2 in the anaesthetized rat.
    Haylor J; Lote CJ; Towers JD
    J Physiol; 1988 Sep; 403():1-14. PubMed ID: 3253420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renal clearance of cefuroxime and ceftazidime and the effect of probenecid on their tubular excretion.
    Verhagen CA; Mattie H; Van Strijen E
    Br J Clin Pharmacol; 1994 Feb; 37(2):193-7. PubMed ID: 8186065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a postsecretory reabsorptive site for uric acid in man.
    Diamond HS; Paolino JS
    J Clin Invest; 1973 Jun; 52(6):1491-9. PubMed ID: 4703233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and the effect of probenecid on the renal excretion mechanism of diprophylline.
    Nadai M; Apichartpichean R; Hasegawa T; Nabeshima T
    J Pharm Sci; 1992 Oct; 81(10):1024-7. PubMed ID: 1432614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonlinear renal excretion of theophylline and its metabolites, 1-methyluric acid and 1,3-dimethyluric acid, in rats.
    Kuh HJ; Shim CK
    Arch Pharm Res; 1994 Apr; 17(2):124-30. PubMed ID: 10319144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal excretion of a slauretic-uricosuric agent (MK-196) and interaction with a urate-retaining drug, pyrazinoate, in the chimpanzee.
    Fanelli GM; Bohn DL; Zacchei AG
    J Pharmacol Exp Ther; 1977 Feb; 200(2):413-9. PubMed ID: 14251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantiomer-enantiomer interaction of a uricosuric antihypertensive diuretic (DBCA) in renal tubular secretion and stereoselective inhibition by probenecid in the cynomolgus monkey.
    Nakano M; Higaki K; Kawahara S
    Xenobiotica; 1993 May; 23(5):525-36. PubMed ID: 8342300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic biotransformation profiles of sulphamonomethoxine in food-producing animals and rats in vitro.
    Furusawa N
    Acta Vet Hung; 2000; 48(3):293-300. PubMed ID: 11402713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of co-administered organic acids on the kinetics and dynamics of frusemide.
    Sommers DK; Meyer EC; Moncrieff J
    Br J Clin Pharmacol; 1991 Oct; 32(4):489-93. PubMed ID: 1958444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the interaction of pyrazinamide and probenecid on urinary uric acid excretion in man.
    Yü TF; Perel J; Berger L; Roboz J; Israili ZH; Dayton PG
    Am J Med; 1977 Nov; 63(5):723-8. PubMed ID: 930947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.